دورية أكاديمية

Multivalent mRNA-DTP vaccines are immunogenic and provide protection from Bordetella pertussis challenge in mice.

التفاصيل البيبلوغرافية
العنوان: Multivalent mRNA-DTP vaccines are immunogenic and provide protection from Bordetella pertussis challenge in mice.
المؤلفون: Wolf, M. Allison, O'Hara, Joanne M., Bitzer, Graham J., Narayanan, Elisabeth, Boehm, Dylan T., Bevere, Justin R., DeJong, Megan A., Hall, Jesse M., Wong, Ting Y., Falcone, Samantha, Deal, Cailin E., Richards, Angelene, Green, Shannon, Nguyen, Brenda, King, Emily, Ogega, Clinton, Russo, Lisa, Sen-Kilic, Emel, Plante, Obadiah, Himansu, Sunny
المصدر: NPJ Vaccines; 6/10/2024, Vol. 9 Issue 1, p1-14, 14p
مصطلحات موضوعية: BORDETELLA pertussis, WHOOPING cough, DPT vaccines, BACTERIAL vaccines, PERTUSSIS toxin, WHOOPING cough vaccines
مستخلص: Acellular multivalent vaccines for pertussis (DTaP and Tdap) prevent symptomatic disease and infant mortality, but immunity to Bordetella pertussis infection wanes significantly over time resulting in cyclic epidemics of pertussis. The messenger RNA (mRNA) vaccine platform provides an opportunity to address complex bacterial infections with an adaptable approach providing Th1-biased responses. In this study, immunogenicity and challenge models were used to evaluate the mRNA platform with multivalent vaccine formulations targeting both B. pertussis antigens and diphtheria and tetanus toxoids. Immunization with mRNA formulations were immunogenetic, induced antigen specific antibodies, as well as Th1 T cell responses. Upon challenge with either historical or contemporary B. pertussis strains, 6 and 10 valent mRNA DTP vaccine provided protection equal to that of 1/20th human doses of either DTaP or whole cell pertussis vaccines. mRNA DTP immunized mice were also protected from pertussis toxin challenge as measured by prevention of lymphocytosis and leukocytosis. Collectively these pre-clinical mouse studies illustrate the potential of the mRNA platform for multivalent bacterial pathogen vaccines. [ABSTRACT FROM AUTHOR]
Copyright of NPJ Vaccines is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:20590105
DOI:10.1038/s41541-024-00890-4